DE69802512D1 - Feste zusammensetzungen für orale verabreichung die alkanoyl-l-carnitin-magnesium-tartrat enthalten - Google Patents

Feste zusammensetzungen für orale verabreichung die alkanoyl-l-carnitin-magnesium-tartrat enthalten

Info

Publication number
DE69802512D1
DE69802512D1 DE69802512T DE69802512T DE69802512D1 DE 69802512 D1 DE69802512 D1 DE 69802512D1 DE 69802512 T DE69802512 T DE 69802512T DE 69802512 T DE69802512 T DE 69802512T DE 69802512 D1 DE69802512 D1 DE 69802512D1
Authority
DE
Germany
Prior art keywords
pct
solid compositions
magnesium tartrate
carnitin
oral administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69802512T
Other languages
English (en)
Other versions
DE69802512T2 (de
Inventor
Ornella Tinti
Nazareno Scafetta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Application granted granted Critical
Publication of DE69802512D1 publication Critical patent/DE69802512D1/de
Publication of DE69802512T2 publication Critical patent/DE69802512T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/105Aliphatic or alicyclic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/245Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/255Tartaric acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
DE69802512T 1997-04-07 1998-03-19 Feste zusammensetzungen für orale verabreichung die alkanoyl-l-carnitin-magnesium-tartrat enthalten Expired - Lifetime DE69802512T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97RM000195A IT1291133B1 (it) 1997-04-07 1997-04-07 Composizioni solide atte alla somministrazione orale comprendenti l-carnitina e alcanoil l-carnitine magnesio tartrato
PCT/IT1998/000059 WO1998045250A1 (en) 1997-04-07 1998-03-19 Solid compositions suitable for oral administration comprising l-carnitine and alkanoyl-l-carnitine magnesium tartrate

Publications (2)

Publication Number Publication Date
DE69802512D1 true DE69802512D1 (de) 2001-12-20
DE69802512T2 DE69802512T2 (de) 2002-08-01

Family

ID=11404944

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69802512T Expired - Lifetime DE69802512T2 (de) 1997-04-07 1998-03-19 Feste zusammensetzungen für orale verabreichung die alkanoyl-l-carnitin-magnesium-tartrat enthalten

Country Status (17)

Country Link
US (1) US6130249A (de)
EP (1) EP0971879B1 (de)
JP (1) JP2001524078A (de)
KR (1) KR100556237B1 (de)
CN (1) CN1177808C (de)
AT (1) ATE208758T1 (de)
AU (1) AU731316B2 (de)
BR (1) BR9808489A (de)
CA (1) CA2285550C (de)
DE (1) DE69802512T2 (de)
DK (1) DK0971879T3 (de)
ES (1) ES2166596T3 (de)
HK (1) HK1025561A1 (de)
IT (1) IT1291133B1 (de)
NZ (1) NZ500538A (de)
PT (1) PT971879E (de)
WO (1) WO1998045250A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1305308B1 (it) * 1999-03-26 2001-05-04 Biosint S P A Granulato ad alto contenuto di l-carnitina o alcanoil-l-carnitina,particolarmente adatto alla produzione di compresse per compressione
JP4539096B2 (ja) * 2004-01-16 2010-09-08 日油株式会社 油性成分被覆l−カルニチン塩粉末およびその用途
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
CN101209975B (zh) 2006-12-29 2010-12-01 沈阳科硕营养科技有限公司 左旋肉碱富马酸钙及其制备方法与用途
US8996409B2 (en) 2007-06-06 2015-03-31 Sony Computer Entertainment Inc. Management of online trading services using mediated communications
EP2425834A1 (de) * 2010-09-06 2012-03-07 Lonza Ltd. Verfahren zur Herstellung von L-Carnitin-Tartrat
US9105178B2 (en) 2012-12-03 2015-08-11 Sony Computer Entertainment Inc. Remote dynamic configuration of telemetry reporting through regular expressions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1153640A (en) * 1967-04-10 1969-05-29 Soc D Etudes Prod Chimique A Carnitin Salt
FR2529545B1 (fr) * 1982-07-02 1985-05-31 Sanofi Sa Nouveaux sels de carnitine ainsi que leur procede de preparation
DE3463261D1 (en) * 1983-12-28 1987-05-27 Sigma Tau Ind Farmaceuti Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same
CA2018137C (en) * 1989-06-14 2000-01-11 Thomas Scholl L-carnitine magnesium citrate
US5073376A (en) * 1989-12-22 1991-12-17 Lonza Ltd. Preparations containing l-carnitine
IT1261688B (it) * 1993-05-28 1996-05-29 Avantgarde Spa Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.

Also Published As

Publication number Publication date
JP2001524078A (ja) 2001-11-27
AU731316B2 (en) 2001-03-29
DE69802512T2 (de) 2002-08-01
IT1291133B1 (it) 1998-12-29
CN1177808C (zh) 2004-12-01
EP0971879A1 (de) 2000-01-19
KR20010005866A (ko) 2001-01-15
ES2166596T3 (es) 2002-04-16
ATE208758T1 (de) 2001-11-15
ITRM970195A1 (it) 1998-10-07
CA2285550C (en) 2008-07-08
CN1251572A (zh) 2000-04-26
EP0971879B1 (de) 2001-11-14
KR100556237B1 (ko) 2006-03-03
DK0971879T3 (da) 2002-03-25
AU6745498A (en) 1998-10-30
PT971879E (pt) 2002-05-31
US6130249A (en) 2000-10-10
NZ500538A (en) 2001-03-30
BR9808489A (pt) 2000-05-23
CA2285550A1 (en) 1998-10-15
WO1998045250A1 (en) 1998-10-15
HK1025561A1 (en) 2000-11-17

Similar Documents

Publication Publication Date Title
DE69806590T2 (de) Feste zusammensetzungen für orale verabreichung die l-carnitine oder alkanoyl-l-carnitin-magnesium-fumarat enthalten
DE69810601D1 (de) Feste zusammensetzungen, die alkanoyl-l-carnitin-magnesium-zitrat enthalten, zur oralen verabreichung
DE69802512D1 (de) Feste zusammensetzungen für orale verabreichung die alkanoyl-l-carnitin-magnesium-tartrat enthalten
DE69802518T2 (de) Feste zusammensetzungen für orale verabreichung die l-carnitin- oder alkanoyl-l- carnitin-cholin-tartrat enthalten
DE69802789D1 (de) Feste zusammensetzungen für orale verabreichung die nicht-hygroskopische salze von l-carnitin-oder alkanoyl-l-carnitin mit 2-aminosulfonsäure enthalten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition